86 related articles for article (PubMed ID: 15055047)
21. Iloprost: an adjunctive approach to chronic viral hepatitis treatment.
Zardi EM; Vespasiani Gentilucci U; Picardi A; Ambrosino G; Fazio VM; Dobrina A; Afeltra A
Med Hypotheses; 2005; 64(1):46-52. PubMed ID: 15533610
[TBL] [Abstract][Full Text] [Related]
22. Hemodynamic effects of a prostacyclin analog (Prostavasin) in systemic scleroderma patients.
Salera D; Argalia G; Giuseppetti GM
Radiol Med; 2005; 110(1-2):106-14. PubMed ID: 16163145
[TBL] [Abstract][Full Text] [Related]
23. Iloprost infusion in diabetic patients with peripheral arterial occlusive disease and foot ulcers.
Mirenda F; La Spada M; Baccellieri D; Stilo F; Benedetto F; Spinelli F
Chir Ital; 2005; 57(6):731-5. PubMed ID: 16400768
[TBL] [Abstract][Full Text] [Related]
24. Haemostatic effects of iloprost in patients with lower limb ischemia.
Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Soraci S; Bartolone S; Bagnato L; Barbera N
Panminerva Med; 1997 Sep; 39(3):202-4. PubMed ID: 9360422
[TBL] [Abstract][Full Text] [Related]
25. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
[TBL] [Abstract][Full Text] [Related]
26. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
de Donato G; Gussoni G; de Donato G
Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
[TBL] [Abstract][Full Text] [Related]
27. Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol.
Milio G; Corrado E; Genova C; Amato C; Raimondi F; Almasio PL; Novo S
Rheumatology (Oxford); 2006 Aug; 45(8):999-1004. PubMed ID: 16484290
[TBL] [Abstract][Full Text] [Related]
28. [Preliminary experimental study on treatment of portal hypertension with auxiliary partial orthotopic liver transplantation].
Shi LB; Peng CH; Peng SY; Liu YB; He W; Xu B; Chen XP; Bai MD; Wang Y; Tang Z
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):730-3. PubMed ID: 15585146
[TBL] [Abstract][Full Text] [Related]
29. Iloprost preserves renal oxygenation and restores kidney function in endotoxemia-related acute renal failure in the rat.
Johannes T; Ince C; Klingel K; Unertl KE; Mik EG
Crit Care Med; 2009 Apr; 37(4):1423-32. PubMed ID: 19318827
[TBL] [Abstract][Full Text] [Related]
30. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
Kramm T; Eberle B; Guth S; Mayer E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
[TBL] [Abstract][Full Text] [Related]
31. Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction.
Theodoraki K; Tsiapras D; Tsourelis L; Zarkalis D; Sfirakis P; Kapetanakis E; Alivizatos P; Antoniou T
Acta Anaesthesiol Scand; 2006 Nov; 50(10):1213-7. PubMed ID: 16978158
[TBL] [Abstract][Full Text] [Related]
32. The cytoprotective effect of iloprost against carbon tetrachloride induced necrosis in rat liver.
Bozkurt S; Ersoy E; Tekýn HE; Bayram O; Anadol Z; Onuk E; Ercan ZS
Res Commun Mol Pathol Pharmacol; 1997 Mar; 95(3):343-6. PubMed ID: 9144840
[TBL] [Abstract][Full Text] [Related]
33. Effects of pentoxifylline and alprostadil on ocular hemodynamics in healthy humans.
Dorner GT; Zawinka C; Resch H; Wolzt M; Schmetterer L; Garhofer G
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):815-9. PubMed ID: 17251482
[TBL] [Abstract][Full Text] [Related]
34. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases.
Sablotzki A; Hentschel T; Hofmann S; Simm A; Mühling J; Czeslick E
J Clin Anesth; 2006 Mar; 18(2):108-13. PubMed ID: 16563327
[TBL] [Abstract][Full Text] [Related]
35. Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation.
Itkin M; Trerotola SO; Stavropoulos SW; Patel A; Mondschein JI; Soulen MC; Tuite CM; Shlansky-Goldberg RD; Faust TW; Reddy KR; Solomon JA; Clark TW
J Vasc Interv Radiol; 2006 Jan; 17(1):55-62. PubMed ID: 16415133
[TBL] [Abstract][Full Text] [Related]
36. Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV).
Meini S; De Franco V; Auteri A; Setacci C; Di Renzo M; Pieragalli D
Int Angiol; 2005 Mar; 24(1):64-9. PubMed ID: 15877001
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of chronic atherosclerotic obliterative arteriopathy in the II and IV Fontaine stage. Personal observations using iloprost].
Marci M; Raffa S; Panzini E; Russo F
Clin Ter; 1994 Dec; 145(12):469-74. PubMed ID: 7536648
[TBL] [Abstract][Full Text] [Related]
38. Doppler sonography measurement of portal blood flow velocity after glucagon injection in patients with chronic HCV infection.
Sereno S; Toccaceli F; Russo V; Iacomi F; Zardi EM; Laghi V
Ultrasound Med Biol; 2001 May; 27(5):723-6. PubMed ID: 11397536
[TBL] [Abstract][Full Text] [Related]
39. Coagulative modifications in patients with systemic sclerosis treated with iloprost or nifedipine.
Candela M; Pansoni A; Jannino L; Menditto VG; Natalini M; Ravaglia F; Da Lio L; Scorza R; Gabrielli A; Danieli G
Ann Ital Med Int; 2001; 16(3):170-4. PubMed ID: 11692906
[TBL] [Abstract][Full Text] [Related]
40. Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock.
Lehmann C; Taymoorian K; Wauer H; Krausch D; Birnbaum J; Kox WJ
Intensive Care Med; 2000 Oct; 26(10):1557-60. PubMed ID: 11126272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
